 | • レポートコード：B-GIR08C6506 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、α-メチルドパの世界市場について調べ、まとめました。種類別セグメントは、経口、点滴、その他等、用途別セグメントは、等に区分しました。α-メチルドパの世界市場概観、企業動向、企業別α-メチルドパシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・α-メチルドパの市場概観 ・α-メチルドパの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・α-メチルドパの企業別販売動向、市場シェア、市場集中度、競争動向 ・α-メチルドパの世界市場規模 ・α-メチルドパの北米市場分析（アメリカ、カナダ、メキシコ等） ・α-メチルドパのアメリカ市場規模推移 ・α-メチルドパのカナダ市場規模推移 ・α-メチルドパのメキシコ市場規模推移 ・α-メチルドパのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・α-メチルドパのドイツ市場規模推移 ・α-メチルドパのイギリス市場規模推移 ・α-メチルドパのロシア市場規模推移 ・α-メチルドパのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・α-メチルドパの日本市場規模推移 ・α-メチルドパの中国市場規模推移 ・α-メチルドパの韓国市場規模推移 ・α-メチルドパのインド市場規模推移 ・α-メチルドパの東南アジア市場規模推移 ・α-メチルドパの南米市場分析（ブラジル、アルゼンチン等） ・α-メチルドパの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・α-メチルドパの種類別分析/販売量、売上、市場シェア（経口、点滴、その他） ・α-メチルドパの用途別分析/市場規模（） ・α-メチルドパの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・α-メチルドパの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global α-Methyldopa market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of α-Methyldopa.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the α-Methyldopa market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the α-Methyldopa market by product type and applications/end industries.
Market Segment by Companies, this report covers
Merck
Icn Pharmaceuticals
Aa Pharma
Pro Doc Ltée
Laboratoires Confab
LGM Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral
Intravenous Drip
Other
Market Segment by Applications, can be divided into
Parkinsonism
Hepatic Coma
Others
Table of Contents
1 α-Methyldopa Market Overview
1.1 Product Overview and Scope of α-Methyldopa
1.2 Classification of α-Methyldopa by Types
1.2.1 Global α-Methyldopa Revenue Comparison by Types (2019-2024)
1.2.2 Global α-Methyldopa Revenue Market Share by Types in 2018
1.2.3 Oral
1.2.4 Intravenous Drip
1.2.5 Other
1.3 Global α-Methyldopa Market by Application
1.3.1 Global α-Methyldopa Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Parkinsonism
1.3.3 Hepatic Coma
1.3.4 Others
1.4 Global α-Methyldopa Market by Regions
1.4.1 Global α-Methyldopa Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) α-Methyldopa Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) α-Methyldopa Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) α-Methyldopa Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) α-Methyldopa Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) α-Methyldopa Status and Prospect (2014-2024)
1.5 Global Market Size of α-Methyldopa (2014-2024)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 α-Methyldopa Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck α-Methyldopa Revenue, Gross Margin and Market Share (2017-2018)
2.2 Icn Pharmaceuticals
2.2.1 Business Overview
2.2.2 α-Methyldopa Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Icn Pharmaceuticals α-Methyldopa Revenue, Gross Margin and Market Share (2017-2018)
2.3 Aa Pharma
2.3.1 Business Overview
2.3.2 α-Methyldopa Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Aa Pharma α-Methyldopa Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pro Doc Ltée
2.4.1 Business Overview
2.4.2 α-Methyldopa Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pro Doc Ltée α-Methyldopa Revenue, Gross Margin and Market Share (2017-2018)
2.5 Laboratoires Confab
2.5.1 Business Overview
2.5.2 α-Methyldopa Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Laboratoires Confab α-Methyldopa Revenue, Gross Margin and Market Share (2017-2018)
2.6 LGM Pharma
2.6.1 Business Overview
2.6.2 α-Methyldopa Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 LGM Pharma α-Methyldopa Revenue, Gross Margin and Market Share (2017-2018)
3 Global α-Methyldopa Market Competition, by Players
3.1 Global α-Methyldopa Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 α-Methyldopa Players Market Share
3.2.2 Top 10 α-Methyldopa Players Market Share
3.3 Market Competition Trend
4 Global α-Methyldopa Market Size by Regions
4.1 Global α-Methyldopa Revenue and Market Share by Regions
4.2 North America α-Methyldopa Revenue and Growth Rate (2014-2019)
4.3 Europe α-Methyldopa Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific α-Methyldopa Revenue and Growth Rate (2014-2019)
4.5 South America α-Methyldopa Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa α-Methyldopa Revenue and Growth Rate (2014-2019)
5 North America α-Methyldopa Revenue by Countries
5.1 North America α-Methyldopa Revenue by Countries (2014-2019)
5.2 USA α-Methyldopa Revenue and Growth Rate (2014-2019)
5.3 Canada α-Methyldopa Revenue and Growth Rate (2014-2019)
5.4 Mexico α-Methyldopa Revenue and Growth Rate (2014-2019)
6 Europe α-Methyldopa Revenue by Countries
6.1 Europe α-Methyldopa Revenue by Countries (2014-2019)
6.2 Germany α-Methyldopa Revenue and Growth Rate (2014-2019)
6.3 UK α-Methyldopa Revenue and Growth Rate (2014-2019)
6.4 France α-Methyldopa Revenue and Growth Rate (2014-2019)
6.5 Russia α-Methyldopa Revenue and Growth Rate (2014-2019)
6.6 Italy α-Methyldopa Revenue and Growth Rate (2014-2019)
7 Asia-Pacific α-Methyldopa Revenue by Countries
7.1 Asia-Pacific α-Methyldopa Revenue by Countries (2014-2019)
7.2 China α-Methyldopa Revenue and Growth Rate (2014-2019)
7.3 Japan α-Methyldopa Revenue and Growth Rate (2014-2019)
7.4 Korea α-Methyldopa Revenue and Growth Rate (2014-2019)
7.5 India α-Methyldopa Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia α-Methyldopa Revenue and Growth Rate (2014-2019)
8 South America α-Methyldopa Revenue by Countries
8.1 South America α-Methyldopa Revenue by Countries (2014-2019)
8.2 Brazil α-Methyldopa Revenue and Growth Rate (2014-2019)
8.3 Argentina α-Methyldopa Revenue and Growth Rate (2014-2019)
8.4 Colombia α-Methyldopa Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue α-Methyldopa by Countries
9.1 Middle East and Africa α-Methyldopa Revenue by Countries (2014-2019)
9.2 Saudi Arabia α-Methyldopa Revenue and Growth Rate (2014-2019)
9.3 UAE α-Methyldopa Revenue and Growth Rate (2014-2019)
9.4 Egypt α-Methyldopa Revenue and Growth Rate (2014-2019)
9.5 Nigeria α-Methyldopa Revenue and Growth Rate (2014-2019)
9.6 South Africa α-Methyldopa Revenue and Growth Rate (2014-2019)
10 Global α-Methyldopa Market Segment by Type
10.1 Global α-Methyldopa Revenue and Market Share by Type (2014-2019)
10.2 Global α-Methyldopa Market Forecast by Type (2019-2024)
10.3 Oral Revenue Growth Rate (2014-2024)
10.4 Intravenous Drip Revenue Growth Rate (2014-2024)
10.5 Other Revenue Growth Rate (2014-2024)
11 Global α-Methyldopa Market Segment by Application
11.1 Global α-Methyldopa Revenue Market Share by Application (2014-2019)
11.2 α-Methyldopa Market Forecast by Application (2019-2024)
11.3 Parkinsonism Revenue Growth (2014-2019)
11.4 Hepatic Coma Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global α-Methyldopa Market Size Forecast (2019-2024)
12.1 Global α-Methyldopa Market Size Forecast (2019-2024)
12.2 Global α-Methyldopa Market Forecast by Regions (2019-2024)
12.3 North America α-Methyldopa Revenue Market Forecast (2019-2024)
12.4 Europe α-Methyldopa Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific α-Methyldopa Revenue Market Forecast (2019-2024)
12.6 South America α-Methyldopa Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa α-Methyldopa Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure α-Methyldopa Picture
Table Product Specifications of α-Methyldopa
Table Global α-Methyldopa and Revenue (Million USD) Market Split by Product Type
Figure Global α-Methyldopa Revenue Market Share by Types in 2018
Figure Oral Picture
Figure Intravenous Drip Picture
Figure Other Picture
Table Global α-Methyldopa Revenue (Million USD) by Application (2014-2024)
Figure α-Methyldopa Revenue Market Share by Applications in 2018
Figure Parkinsonism Picture
Figure Hepatic Coma Picture
Figure Others Picture
Table Global Market α-Methyldopa Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America α-Methyldopa Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe α-Methyldopa Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific α-Methyldopa Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America α-Methyldopa Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa α-Methyldopa Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global α-Methyldopa Revenue (Million USD) and Growth Rate (2014-2024)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck α-Methyldopa Type and Applications
Table Merck α-Methyldopa Revenue, Gross Margin and Market Share (2017-2018)
Table Icn Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Icn Pharmaceuticals α-Methyldopa Type and Applications
Table Icn Pharmaceuticals α-Methyldopa Revenue, Gross Margin and Market Share (2017-2018)
Table Aa Pharma Basic Information, Manufacturing Base and Competitors
Table Aa Pharma α-Methyldopa Type and Applications
Table Aa Pharma α-Methyldopa Revenue, Gross Margin and Market Share (2017-2018)
Table Pro Doc Ltée Basic Information, Manufacturing Base and Competitors
Table Pro Doc Ltée α-Methyldopa Type and Applications
Table Pro Doc Ltée α-Methyldopa Revenue, Gross Margin and Market Share (2017-2018)
Table Laboratoires Confab Basic Information, Manufacturing Base and Competitors
Table Laboratoires Confab α-Methyldopa Type and Applications
Table Laboratoires Confab α-Methyldopa Revenue, Gross Margin and Market Share (2017-2018)
Table LGM Pharma Basic Information, Manufacturing Base and Competitors
Table LGM Pharma α-Methyldopa Type and Applications
Table LGM Pharma α-Methyldopa Revenue, Gross Margin and Market Share (2017-2018)
Table Global α-Methyldopa Revenue (Million USD) by Players (2014-2019)
Table Global α-Methyldopa Revenue Share by Players (2014-2019)
Figure Global α-Methyldopa Revenue Share by Players in 2017
Figure Global α-Methyldopa Revenue Share by Players in 2018
Figure Global Top 5 Players α-Methyldopa Revenue Market Share in 2018
Figure Global Top 10 Players α-Methyldopa Revenue Market Share in 2018
Figure Global α-Methyldopa Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global α-Methyldopa Revenue (Million USD) by Regions (2014-2019)
Table Global α-Methyldopa Revenue Market Share by Regions (2014-2019)
Figure Global α-Methyldopa Revenue Market Share by Regions (2014-2019)
Figure Global α-Methyldopa Revenue Market Share by Regions in 2018
Figure North America α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure Europe α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure South America α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa α-Methyldopa Revenue and Growth Rate (2014-2019)
Table North America α-Methyldopa Revenue by Countries (2014-2019)
Table North America α-Methyldopa Revenue Market Share by Countries (2014-2019)
Figure North America α-Methyldopa Revenue Market Share by Countries (2014-2019)
Figure North America α-Methyldopa Revenue Market Share by Countries in 2018
Figure USA α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure Canada α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure Mexico α-Methyldopa Revenue and Growth Rate (2014-2019)
Table Europe α-Methyldopa Revenue (Million USD) by Countries (2014-2019)
Figure Europe α-Methyldopa Revenue Market Share by Countries (2014-2019)
Figure Europe α-Methyldopa Revenue Market Share by Countries in 2018
Figure Germany α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure UK α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure France α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure Russia α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure Italy α-Methyldopa Revenue and Growth Rate (2014-2019)
Table Asia-Pacific α-Methyldopa Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific α-Methyldopa Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific α-Methyldopa Revenue Market Share by Countries in 2018
Figure China α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure Japan α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure Korea α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure India α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure Southeast Asia α-Methyldopa Revenue and Growth Rate (2014-2019)
Table South America α-Methyldopa Revenue by Countries (2014-2019)
Table South America α-Methyldopa Revenue Market Share by Countries (2014-2019)
Figure South America α-Methyldopa Revenue Market Share by Countries (2014-2019)
Figure South America α-Methyldopa Revenue Market Share by Countries in 2018
Figure Brazil α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure Argentina α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure Colombia α-Methyldopa Revenue and Growth Rate (2014-2019)
Table Middle East and Africa α-Methyldopa Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa α-Methyldopa Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa α-Methyldopa Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa α-Methyldopa Revenue Market Share by Countries in 2018
Figure Saudi Arabia α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure UAE α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure Egypt α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure Nigeria α-Methyldopa Revenue and Growth Rate (2014-2019)
Figure South Africa α-Methyldopa Revenue and Growth Rate (2014-2019)
Table Global α-Methyldopa Revenue (Million USD) by Type (2014-2019)
Table Global α-Methyldopa Revenue Share by Type (2014-2019)
Figure Global α-Methyldopa Revenue Share by Type (2014-2019)
Figure Global α-Methyldopa Revenue Share by Type in 2018
Table Global α-Methyldopa Revenue Forecast by Type (2019-2024)
Figure Global α-Methyldopa Market Share Forecast by Type (2019-2024)
Figure Global Oral Revenue Growth Rate (2014-2019)
Figure Global Intravenous Drip Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global α-Methyldopa Revenue by Application (2014-2019)
Table Global α-Methyldopa Revenue Share by Application (2014-2019)
Figure Global α-Methyldopa Revenue Share by Application (2014-2019)
Figure Global α-Methyldopa Revenue Share by Application in 2018
Table Global α-Methyldopa Revenue Forecast by Application (2019-2024)
Figure Global α-Methyldopa Market Share Forecast by Application (2019-2024)
Figure Global Parkinsonism Revenue Growth Rate (2014-2019)
Figure Global Hepatic Coma Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global α-Methyldopa Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global α-Methyldopa Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global α-Methyldopa Revenue Market Share Forecast by Regions (2019-2024)
Figure North America α-Methyldopa Revenue Market Forecast (2019-2024)
Figure Europe α-Methyldopa Revenue Market Forecast (2019-2024)
Figure Asia-Pacific α-Methyldopa Revenue Market Forecast (2019-2024)
Figure South America α-Methyldopa Revenue Market Forecast (2019-2024)
Figure Middle East and Africa α-Methyldopa Revenue Market Forecast (2019-2024)
α2アドレナリン作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global α2 Adrenergic Agonist market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, als…- メトキサミンの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Methoxamine market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast gro…
- ノルエピネフリン/ノルアドレナリンの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Norepinephrine/Noradrenaline market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Chi…
- 世界の明白な肝性脳症市場：市場規模・現状・予測 Hepatic encephalopathy (HE) is an altered level of consciousness as a result of liver failure. Onset may be gradual or sudden. Other symptoms may include movement problems, changes in mood, or changes in personality. In the advanced stages it can result in a coma.Overt hepatic encephalopathy develop…
- フェニレフリンの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Phenylephrine market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast g…